Actively Recruiting
Electroconvulsive Therapy Augmented With Transcranial Magnetic Stimulation for Treatment Resistant Depression
Led by Charles University, Czech Republic · Updated on 2026-01-07
50
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The RTMSECT2 study was design to compare the application of electroconvulsive therapy augmented by transcranial magnetic stimulation. Subject will be compared both within groups and in group using psychometric scales and different deliver energy
CONDITIONS
Official Title
Electroconvulsive Therapy Augmented With Transcranial Magnetic Stimulation for Treatment Resistant Depression
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Montgomery-Asberg Depression Scale (MADRS) score of 20 or higher
- Diagnosis of major depressive disorder according to ICD 10
You will not qualify if you...
- Presence of other Axis I disorders such as schizophrenia or addiction
- Diagnosis of dementia
- Electroconvulsive therapy (ECT) received in the last 3 months
- Transcranial magnetic stimulation (TMS) received in the last 3 months
- Psychotic diseases or symptoms
- Pregnancy or breastfeeding
- Any neurological disease such as epilepsy
- Participation in another clinical trial within the last 30 days
- Any medical condition that contraindicates ECT
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
General University Hospital, Psychiatry department
Prague, Czech, Czechia, 120 39
Actively Recruiting
Research Team
D
Daniel Divacky
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
FACTORIAL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here